Changes in cellular function in the TME and altered molecular pathways in DCs suggested that TIM-3 deficiency activates inflammasomes in DCs, which maintains the proliferative activity of CD8+ T cells and increases their tumor-killing capacity (70). Here, CD8A is linked to neoplasm.